Conducto arterioso persistente en el recién nacido prematuro

EMC - Pediatría - Tập 53 - Trang 1-8 - 2018
P. Morville1
1Cardiologie pédiatrique, Polyclinique Courlancy, rue de Courlancy, 51100 Reims, France

Tài liệu tham khảo

Rozé, 2015, Hemodynamic EPIPAGE 2 Study Group. Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm Infants, JAMA, 313, 2441, 10.1001/jama.2015.6734 Gittenberger-de Groot, 1980, The ductus arteriosus in the preterm infant: histologic and clinical observations, J Pediatr, 96, 88, 10.1016/S0022-3476(80)80337-4 Clyman, 2002, VEGF regulates remodeling during permanent anatomic closure of the ductus arteriosus, Am J Physiol Regul Integr Comp Physiol, 282, R199, 10.1152/ajpregu.00298.2001 Kajino, 2001, Factors that increase the contractile tone of the ductus arteriosus also regulate its anatomic remodeling, Am J Physiol Regul Integr Comp Physiol, 281, R291, 10.1152/ajpregu.2001.281.1.R291 Waleh, 2004, Prostaglandin E2--mediated relaxation of the ductus arteriosus: effects of gestational age on G protein-coupled receptor expression, signaling, and vasomotor control, Circulation, 110, 2326, 10.1161/01.CIR.0000145159.16637.5D Thébaud, 2004, Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus, Circulation, 110, 1372, 10.1161/01.CIR.0000141292.28616.65 Coceani, 1999, Endothelin A receptor is necessary for O(2) constriction but not closure of ductus arteriosus, Am J Physiol, 277, H1521 Kajimoto, 2007, Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction, Circulation, 115, 1777, 10.1161/CIRCULATIONAHA.106.649566 Kajimura, 2016, Lipopolysaccharide delays closure of the rat ductus arteriosus by induction of inducible nitric oxide synthase but not prostaglandin E2, Circ J, 80, 703, 10.1253/circj.CJ-15-1053 Bustamante, 1996, Inducible nitric oxide synthase and the regulation of central vessel caliber in the fetal rat, Circulation, 94, 1948, 10.1161/01.CIR.94.8.1948 Park, 2015, Chorioamnionitis and patent ductus arteriosus: a systematic review and meta-analysis, PLoS One, 10, e0138114, 10.1371/journal.pone.0138114 Behbodi, 2016, Chorioamnionitis appears not to be a risk factor for patent ductus arteriosus in preterm infants: a systematic review and meta-analysis, Sci Rep, 6, 37967, 10.1038/srep37967 Aghajafari, 2001, Multiple courses of antenatal corticosteroids: a systematic review and meta-analysis, Am J Obstet Gynecol, 185, 1073, 10.1067/mob.2001.117635 Echtler, 2010, Platelets contribute to postnatal occlusion of the ductus arteriosus, Nat Med, 16, 75, 10.1038/nm.2060 Horbar, 1995, The Vermont-Oxford Neonatal Network: integrating research and clinical practice to improve the quality of medical care, Semin Perinatol, 19, 124, 10.1016/S0146-0005(05)80032-1 Lavoie, 2008, Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institute of health, Pediatrics, 122, 479, 10.1542/peds.2007-2313 Bhandari, 2009, Genetic contribution to patent ductus arteriosus in the premature newborn, Pediatrics, 123, 669, 10.1542/peds.2008-1117 Dagle, 2009, Determination of genetic predisposition to patent ductus arteriosus in preterm infants, Pediatrics, 123, 1116, 10.1542/peds.2008-0313 MacNamara, 2007, Towards rational management of the patent ductus arteriosus: the need for disease staging, Arch Dis Child Fetal Neonatal Ed, 92, 424, 10.1136/adc.2007.118117 Su, 1997, Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants, Arch Dis Child Fetal Neonatal Ed, 77, F36, 10.1136/fn.77.1.F36 Kluckow, 1995, Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation, J Pediatr, 127, 774, 10.1016/S0022-3476(95)70172-9 Kwinta, 2009, Can early echocardiographic findings predict patent ductus arteriosus?, Neonatology, 95, 141, 10.1159/000153098 Evans, 1995, Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes, Arch Dis Child Fetal Neonatal Ed, 72, 10.1136/fn.72.3.F156 El Hajjar, 2005, Severity of the ductal shunt: a comparison of different markers. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants, Arch Dis Child Fetal Neonatal Ed, 90 Condò, 2012, Echocardiographic assessment of ductal significance: retrospective comparison of two methods, Arch Dis Child Fetal Neonatal Ed, 97, F35, 10.1136/adc.2010.207233 Evans, 1996, Early ductal shunting and intraventricular haemorraghe in ventilated preterm infants, Arch Dis Child Fetal and Neonatal Ed, 75, 183, 10.1136/fn.75.3.F183 Dix, 2016, Cerebral oxygenation and echocardiographic parameters in preterm neonates with a patent ductus arteriosus: an observational study, Arch Dis Child Fetal Neonatal Ed, 10.1136/archdischild-2015-309192 Alderliesten, 2015, Perfusion index in preterm infants during the first 3 days of life: reference values and relation with clinical variables, Neonatology, 107, 258, 10.1159/000370192 Sellmer, 2013, Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3, Arch Dis Child Fetal Neonatal Ed, 98, F505, 10.1136/archdischild-2013-303816 Noori, 2009, Failure of ductus arteriosus closure is associated with increased mortality in preterm infants, Pediatrics, 123, e138, 10.1542/peds.2008-2418 Marshall, 1999, Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association, Pediatrics, 104, 1345, 10.1542/peds.104.6.1345 Schmidt, 2006, Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP), J Pediatr, 148, 730, 10.1016/j.jpeds.2006.01.047 Adrouche-Amrani, 2012, Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants, BMC Pediatr, 12, 10, 10.1186/1471-2431-12-10 Chang, 2008, Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus, Pediatr Res, 63, 299, 10.1203/PDR.0b013e318163a8e4 Collaco, 2016, Risk factors and clinical outcomes in preterm infants with pulmonary hypertension, PLoS One, 11, e0163904, 10.1371/journal.pone.0163904 Yee, 2012, Does primary surgical closure of the patent ductus arteriosus in infants <1500 g or ≤32 weeks’ gestation reduce the incidence of necrotizing enterocolitis?, Paediatr Child Health, 17, 125, 10.1093/pch/17.3.125 Clyman, 2013, Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus, J Pediatr, 163, 406, 10.1016/j.jpeds.2013.01.057 Buddhe, 2012, NT-proBNP levels improve the ability of predicting a hemodynamically significant patent ductus arteriosus in very low-birth-weight infants, J Clin Neonatol, 1, 82, 10.4103/2249-4847.96758 König, 2015, B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants, Acta Paediatr, 104, e139, 10.1111/apa.12892 Kulkarni, 2015, Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review, Pediatrics, 135, e510, 10.1542/peds.2014-1995 Vanhaesebrouck, 2007, Conservative treatment for patent ductus arteriosus in the preterm, Arch Dis Child Fetal Neonatal Ed, 92, F244, 10.1136/adc.2006.104596 Kaempf, 2012, What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?, J Perinatol, 32, 344, 10.1038/jp.2011.102 Sung, 2016, Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants, J Pediatr, 177, 66, 10.1016/j.jpeds.2016.06.046 De Buyst, 2012, Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus, J Pediatr, 16, 404, 10.1016/j.jpeds.2012.03.012 Stephens, 2008, Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants, J Perinatol, 28, 123, 10.1038/sj.jp.7211895 Heyman, 1976, Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis, N Engl J Med, 295, 530, 10.1056/NEJM197609022951004 Su, 2015, Neonatal outcomes of extremely preterm infants from Taiwan: comparison with Canada, Japan, and the USA, Pediatr Neonatol, 56, 46, 10.1016/j.pedneo.2014.05.002 Fowlie, 2010, Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants, Cochrane Database Syst Rev, CD000174 Schmidt, 2006, Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analysis from the Trial of Indomethacin prophylaxis in preterm (TIPP), J Pediatr, 148, 730, 10.1016/j.jpeds.2006.01.047 Mirza, 2016, Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants, Arch Dis Child Fetal Neonatal Ed, 101, F418, 10.1136/archdischild-2015-309112 Kluckow, 2014, A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus, Arch Dis Child Fetal Neonatal Ed, 99, F99, 10.1136/archdischild-2013-304695 Clyman, 1996, Recommendations for the postnatal use of indomethacin: an analysis of four separates treatment strategies, J Pediatr, 128, 601, 10.1016/S0022-3476(96)80123-5 Van Overmeire, 2001, Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome, J Pediatr, 138, 205, 10.1067/mpd.2001.110528 Christmann, 2002, Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin, Acta Paediatr, 91, 440, 10.1111/j.1651-2227.2002.tb01668.x Hammerman, 2008, Ibuprofen versus continuous indomethacin in premature infants with patent ductus arteriosus: is the difference in the mode of administration?, Pediatr Res, 64, 291, 10.1203/PDR.0b013e31817d9bb0 Sangem, 2008, Multiple courses of Indomethacin and neonatal outcomes in premature infants, Pediatr Cardiol, 29, 878, 10.1007/s00246-007-9166-z Olhsson, 2015, Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants, Cochrane Database Syst Rev Hirt, 2008, An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study, Br J Clin Pharmacol, 65, 629, 10.1111/j.1365-2125.2008.03118.x Lin, 2016, Randomized trial to compare renal function and ductal response between indomethacin and ibuprofen treatment in extremely low birth weight infants, Neonatology, 111, 195, 10.1159/000450822 Gubhaju, 2011, Preterm birth and the kidney: implications for long-term renal health, J Reprod Sci, 18, 322, 10.1177/1933719111401659 Desfrere, 2012, Unbound bilirubin does not increase during ibuprofen treatment of patent ductus arteriosus in preterm infants, J Pediatr, 160, 258, 10.1016/j.jpeds.2011.07.014 Gulack, 2015, Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus, Early Hum Dev, 91, 725, 10.1016/j.earlhumdev.2015.08.003 Chamaa, 2000, The renal hemodynamic effects of ibuprofen in the newborn rabbit, Pediatr Res, 48, 600, 10.1203/00006450-200011000-00008 Sharma, 2010, Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis, J Perinatal, 30, 786, 10.1038/jp.2010.59 Gournay, 2002, Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants, Lancet, 359, 1486, 10.1016/S0140-6736(02)08424-6 Jones, 2011, Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants, Arch Dis Child Fetal Neonatal Ed, 96, F45, 10.1136/adc.2009.168682 Ohlsson, 2015, Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants, Cochrane Database Syst Rev Hammerman, 2011, Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment, Pediatrics, 128, 1618, 10.1542/peds.2011-0359 Stoll, 2010, Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network, Pediatrics, 126, 443, 10.1542/peds.2009-2959 Younge, 2017, Survival and neurodevelopmental outcomes among periviable infants, N Engl J Med, 376, 617, 10.1056/NEJMoa1605566 Mosalli, 2008, Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants, Cochrane Database Syst Rev Cotton, 1978, Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants, J Pediatr, 93, 647, 10.1016/S0022-3476(78)80910-X Ibrahim, 2015, Outcomes of early ligation of patent ductus arteriosus in preterms, multicenter experience, Medicine, 94, e915, 10.1097/MD.0000000000000915 Clement, 2008, Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weigth infants, Arch Otolaryngol Head Neck Surg, 134, 28, 10.1001/archoto.2007.2 Smith, 2009, Should all newborns who undergo patent ductus arteriosus ligation be examined for vocal fold mobility?, Laryngoscope, 119, 1606, 10.1002/lary.20148 Fouilloux, 2014, Surgical closure of persistent arterial duct with minimal invasive anterior thoracotomy: an alternative technique, Eur J Pediatr Surg, 24, 431 Madan, 2009, Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome, Pediatrics, 123, 674, 10.1542/peds.2007-2781 Bourgoin, 2016, Neurodevelopmental outcome at 2 years of age according to patent ductus arteriosus management in very preterm infants, Neonatalogy, 109, 139, 10.1159/000442278 Francis, 2010, Transcatheter occlusion of patent ductus arteriosus in pre-term infants, JACC Cardiovasc Interv, 3, 550, 10.1016/j.jcin.2010.01.016 Bass, 2014, Transcatheter occlusion of the patent ductus arteriosus in infants: experimental testing of a new Amplatzer device, Catheter Cardiovasc Interv, 83, 250, 10.1002/ccd.22931 Morville, 2017, Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by Amplatzer ductal occluder additional size-ADOIIAS, Catheter Cardiovasc Interv, 10.1002/ccd.27091